-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Investigating the Role of the R525H DDX41 Somatic Variant in the Context of DDX41 Mutant Germline Predisposition Syndrome

Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: DDX41-Mediated Malignancies
Friday, December 6, 2024, 2:41 PM-3:25 PM

Ludovica Marando, MD, PhD

Mayo Clinic, Rochester; University of Cambridge, Cambridge, United Kingdom

Disclosures: No relevant conflicts of interest to declare.

See more of: DDX41-Mediated Malignancies
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>